GERARDO MAZZELLA
GERARDO MAZZELLA
Introduction: The role of direct acting antivirals (DAAs) for hepatitis C virus (HCV) in hepatocellular carcinoma (HCC) recurrence is a source of great debate. Current evidence is unable to determine whether DAAs increases or decreases risk of recurrence. However, it has not been investigated the role of DAAs in patients undergoing orthotopic liver transplantation (OLT) for HCC. As a post-OLT recurrence is a deadly event, we compared the risk of recurrence and the overall survival (OS) of patients treated with DAA and obtaining SVR before OLT with an historical cohort of patients transplanted for HCC before the arrival of DAAs.
To read this article in full you will need to make a payment
Purchase one-time access
Subscribe to Digestive and Liver Disease
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article Info
Identification
DOI: https://doi.org/10.1016/j.dld.2019.12.086
Copyright
© 2019 Published by Elsevier Inc.
ScienceDirect
Access this article on ScienceDirect
Related Articles
Outcome after liver transplantation in elderly recipients (>65 years) — A single-center retrospective analysis
Digestive and Liver DiseaseVol. 50Issue 10
In BriefFull-TextPDF
Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series
Digestive and Liver DiseaseVol. 50Issue 7
In BriefFull-TextPDF
From individual to population-based benefit of split liver transplantation
Digestive and Liver DiseaseVol. 51Issue 2
In BriefFull-TextPDF
Common issues in the management of patients in the waiting list and after liver transplantation
Digestive and Liver DiseaseVol. 49Issue 3
In BriefFull-TextPDF
Right lobe split liver graft versus whole liver transplantation: A systematic review by updated traditional and cumulative meta-analysis
Digestive and Liver DiseaseVol. 50Issue 12
In BriefFull-TextPDF
Non-alcoholic steatohepatitis and liver transplantation
Digestive and Liver DiseaseVol. 48Issue 6
In BriefFull-TextPDF
Liver transplant for hepatocellular carcinoma: A heavyweight therapeutic option in need of a new policy on liver graft allocation
Digestive and Liver DiseaseVol. 50Issue 12
In BriefFull-TextPDF
Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma
Digestive and Liver DiseaseVol. 52Issue 1
In BriefFull-TextPDF
Fat soluble vitamins deficiency in pediatric chronic liver disease: The impact of liver transplantation
Digestive and Liver DiseaseVol. 52Issue 3
In BriefFull-TextPDF
Liver transplantation and combined hepatocellular-cholangiocarcinoma: Feasibility and outcomes
Digestive and Liver DiseaseVol. 49Issue 5
In BriefFull-TextPDF
GERARDO MAZZELLA
Home
ARTICLES & ISSUES
Articles In Press
Current Issue
List of Issues
Supplements
COLLECTIONS
Cirrhosis and Portal Hypertension
Digestive and Liver Disease Supplements
What's New in IBD Management
Reviews
Editor's Choice
FOR AUTHORS
Author Information
Permissions
Researcher Academy
Submit a Manuscript
JOURNAL INFO
About the Journal
Abstracting/Indexing
Activate Online Access
Career Opportunities
Contact Information
Editorial Board
Mobile Access Instructions
Pricing
Reprints
New Content Alerts
News and Media
Subscribe
SOCIETY INFO
Associazione Italiana Gastroenterologi e Endoscopisti Digestivi Ospedalieri - AIGO
Associazione Italiana per lo Studio del Fegato - AISF
Associazione Italiana per lo Studio del Pancreas - AISP
Italian Group for the Study of Inflammatory Bowel Disease - IG-IBD
Societa Italiana Endoscopia Digestiva - SIED
La Societa Italiana di Gastroenterologia ed Endoscopia Digestiva - SIGE
Societa Italiana Gastroenterologia, Epatologia e Nutrizione Pediatrica - SIGENP
MORE PERIODICALS
Find a Periodical
Go to Product Catalog
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the Use of Cookies.
Copyright © 2020 Elsevier Inc. except certain content provided by third parties.
Privacy Policy Terms and Conditions Accessibility Help & Contact
RELX
Advertisement
Comments
Post a Comment